These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
580 related articles for article (PubMed ID: 23525005)
1. E-cadherin-integrin crosstalk in cancer invasion and metastasis. Canel M; Serrels A; Frame MC; Brunton VG J Cell Sci; 2013 Jan; 126(Pt 2):393-401. PubMed ID: 23525005 [TBL] [Abstract][Full Text] [Related]
2. Regulation of cell motile behavior by crosstalk between cadherin- and integrin-mediated adhesions. Borghi N; Lowndes M; Maruthamuthu V; Gardel ML; Nelson WJ Proc Natl Acad Sci U S A; 2010 Jul; 107(30):13324-9. PubMed ID: 20566866 [TBL] [Abstract][Full Text] [Related]
3. Quantitative in vivo imaging of the effects of inhibiting integrin signaling via Src and FAK on cancer cell movement: effects on E-cadherin dynamics. Canel M; Serrels A; Miller D; Timpson P; Serrels B; Frame MC; Brunton VG Cancer Res; 2010 Nov; 70(22):9413-22. PubMed ID: 21045155 [TBL] [Abstract][Full Text] [Related]
4. Loss of cell-cell contact is induced by integrin-mediated cell-substratum adhesion in highly-motile and highly-metastatic hepatocellular carcinoma cells. Genda T; Sakamoto M; Ichida T; Asakura H; Hirohashi S Lab Invest; 2000 Mar; 80(3):387-94. PubMed ID: 10744074 [TBL] [Abstract][Full Text] [Related]
5. The SRC-induced mesenchymal state in late-stage colon cancer cells. Avizienyte E; Brunton VG; Fincham VJ; Frame MC Cells Tissues Organs; 2005; 179(1-2):73-80. PubMed ID: 15942195 [TBL] [Abstract][Full Text] [Related]
6. Src SH3/2 domain-mediated peripheral accumulation of Src and phospho-myosin is linked to deregulation of E-cadherin and the epithelial-mesenchymal transition. Avizienyte E; Fincham VJ; Brunton VG; Frame MC Mol Biol Cell; 2004 Jun; 15(6):2794-803. PubMed ID: 15075377 [TBL] [Abstract][Full Text] [Related]
7. Induction of cell scattering by expression of beta1 integrins in beta1-deficient epithelial cells requires activation of members of the rho family of GTPases and downregulation of cadherin and catenin function. Gimond C; van Der Flier A; van Delft S; Brakebusch C; Kuikman I; Collard JG; Fässler R; Sonnenberg A J Cell Biol; 1999 Dec; 147(6):1325-40. PubMed ID: 10601344 [TBL] [Abstract][Full Text] [Related]
8. E-cadherin endocytosis regulates the activity of Rap1: a traffic light GTPase at the crossroads between cadherin and integrin function. Balzac F; Avolio M; Degani S; Kaverina I; Torti M; Silengo L; Small JV; Retta SF J Cell Sci; 2005 Oct; 118(Pt 20):4765-83. PubMed ID: 16219685 [TBL] [Abstract][Full Text] [Related]
14. Src-induced de-regulation of E-cadherin in colon cancer cells requires integrin signalling. Avizienyte E; Wyke AW; Jones RJ; McLean GW; Westhoff MA; Brunton VG; Frame MC Nat Cell Biol; 2002 Aug; 4(8):632-8. PubMed ID: 12134161 [TBL] [Abstract][Full Text] [Related]
15. N-cadherin in the spotlight of cell-cell adhesion, differentiation, embryogenesis, invasion and signalling. Derycke LD; Bracke ME Int J Dev Biol; 2004; 48(5-6):463-76. PubMed ID: 15349821 [TBL] [Abstract][Full Text] [Related]
16. Focal adhesion kinase and its potential involvement in tumor invasion and metastasis. Kornberg LJ Head Neck; 1998 Dec; 20(8):745-52. PubMed ID: 9790298 [TBL] [Abstract][Full Text] [Related]
18. Tumor progression: the role of cadherins and integrins. Glukhova M; Deugnier MA; Thiery JP Mol Med Today; 1995 May; 1(2):84-9. PubMed ID: 17607900 [TBL] [Abstract][Full Text] [Related]
19. Engagement of collagen-binding integrins promotes matrix metalloproteinase-9-dependent E-cadherin ectodomain shedding in ovarian carcinoma cells. Symowicz J; Adley BP; Gleason KJ; Johnson JJ; Ghosh S; Fishman DA; Hudson LG; Stack MS Cancer Res; 2007 Mar; 67(5):2030-9. PubMed ID: 17332331 [TBL] [Abstract][Full Text] [Related]
20. Integrin β1 orchestrates the abnormal cell-matrix attachment and invasive behaviour of E-cadherin dysfunctional cells. Figueiredo J; Ferreira RM; Xu H; Gonçalves M; Barros-Carvalho A; Cravo J; Maia AF; Carneiro P; Figueiredo C; Smith ML; Stamenović D; Morais-de-Sá E; Seruca R Gastric Cancer; 2022 Jan; 25(1):124-137. PubMed ID: 34486077 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]